Sanofi receives FDA complete response letter for MS drug tolebrutinib – Investing.com

Company News · Earnings · Investment Ideas · SWOT Analysis · Analyst Ratings … Investing.com — Sanofi SA (EPA:SASY) announced that the U.S. Food and …